Making breakthrough discoveries in the fundamental causes of cancer, and translating these into prevention and treatment.
Excludes commercial-in-confidence projects.
Research since 2008 is shown below.
To see earlier years visit
ORCID or ResearcherID or
Open access indicates that an output is open access.
Staudacher, AH, Li, Y, Liapis, V, Hou, JJC, Chin, D, Dolezal, O, Adams, TE, van Berkel, PH & Brown, MP 2019, 'APOMAB antibody-drug conjugates targeting dead tumor cells are effective in vivo', Molecular Cancer Therapeutics, vol. 18, no. 2, pp. 335-345.
External engagement & recognition